Invention Grant
- Patent Title: sFRP expression enhancing agent
- Patent Title (中): sFRP表达增强剂
-
Application No.: US10594695Application Date: 2005-03-30
-
Publication No.: US07705196B2Publication Date: 2010-04-27
- Inventor: Tetsu Akiyama , Takefumi Ishidao , Tomoiki Aiba
- Applicant: Tetsu Akiyama , Takefumi Ishidao , Tomoiki Aiba
- Applicant Address: JP Tokyo
- Assignee: Daiichi Pharmaceutical Co., Ltd.
- Current Assignee: Daiichi Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Kilyk & Bowersox, P.L.L.C.
- Priority: JP2004-106315 20040331
- International Application: PCT/JP2005/006163 WO 20050330
- International Announcement: WO2005/094887 WO 20051013
- Main IPC: G01N33/00
- IPC: G01N33/00 ; C12Q1/00

Abstract:
Tumor formation and reduced transcription of both sFRP1 gene and sFRP2 gene were found in Dlg gene knock-out mice, and thereby the following has been provided: an agent for enhancing the expression and/or function of sFRP, containing a compound having an effect of enhancing the expression and/or function of Dlg; an agent for inhibiting tumor formation or an agent for preventing and/or treating a tumor disease, containing the agent for enhancing the expression and/or function of sFRP; a method of enhancing the expression and/or function of sFRP, comprising enhancing the expression and/or function of Dlg; a method of inhibiting tumor formation or a method of preventing and/or treating a tumor disease, comprising using the aforementioned enhancing agent or the aforementioned enhancing method; a non-human mammal that is deficient in one or both of Dlg alleles; a cell originating in the mammal; a method of identifying a compound, comprising using the mammal or the cell; and a method of examining a tumor tissue or a tumor cell, comprising measuring the expression and/or function of Dlg.
Public/Granted literature
- US20080227695A1 Sfrp Expression Enhancing Agent Public/Granted day:2008-09-18
Information query